tiprankstipranks
Advertisement
Advertisement

APLIF Stock Latest News

Appili Therapeutics Targets New Funding and Partnerships at World Vaccine Congress Washington
Company AnnouncementsAppili Therapeutics Targets New Funding and Partnerships at World Vaccine Congress Washington
7d ago
Appili Therapeutics Raises C$100,000 in Second Tranche of Private Placement
PremiumCompany Announcements
Appili Therapeutics Raises C$100,000 in Second Tranche of Private Placement
2M ago
Appili Deepens Non-Dilutive Funding Base as Infectious Disease Pipeline Advances
PremiumCompany Announcements
Appili Deepens Non-Dilutive Funding Base as Infectious Disease Pipeline Advances
2M ago
Appili Therapeutics Raises C$177,500 in First Tranche of Private Placement
PremiumCompany Announcements
Appili Therapeutics Raises C$177,500 in First Tranche of Private Placement
4M ago
Appili Therapeutics Reports Strong Q2 Results and Secures Major Funding for Infectious Disease Programs
PremiumCompany Announcements
Appili Therapeutics Reports Strong Q2 Results and Secures Major Funding for Infectious Disease Programs
5M ago
Appili Therapeutics Launches C$750,000 Private Placement to Boost Drug Development
PremiumCompany AnnouncementsAppili Therapeutics Launches C$750,000 Private Placement to Boost Drug Development
5M ago
Appili Therapeutics prices 30M units at $0.025 in private placement
Premium
The Fly
Appili Therapeutics prices 30M units at $0.025 in private placement
5M ago
Appili Therapeutics to Showcase Biodefense Innovations at BARDA Symposium
Premium
Company Announcements
Appili Therapeutics to Showcase Biodefense Innovations at BARDA Symposium
6M ago
Appili Therapeutics Secures $40 Million Contract for Fungal Vaccine Development
PremiumCompany Announcements
Appili Therapeutics Secures $40 Million Contract for Fungal Vaccine Development
6M ago
Appili Therapeutics, Vitalix awarded up to $40M contract from NIAID
PremiumThe Fly
Appili Therapeutics, Vitalix awarded up to $40M contract from NIAID
6M ago
Appili Therapeutics Secures Shareholder Approval for Strategic Initiatives
PremiumCompany Announcements
Appili Therapeutics Secures Shareholder Approval for Strategic Initiatives
6M ago
Appili Therapeutics to Showcase Tularemia Vaccine at NATO Conference
PremiumCompany Announcements
Appili Therapeutics to Showcase Tularemia Vaccine at NATO Conference
7M ago
Appili Therapeutics to present progress on Tularemia vaccine
PremiumThe FlyAppili Therapeutics to present progress on Tularemia vaccine
7M ago
Appili Therapeutics Strengthens Biodefense Partnerships and Advances Drug Development
Premium
Company Announcements
Appili Therapeutics Strengthens Biodefense Partnerships and Advances Drug Development
8M ago
Appili Therapeutics, colleagues publish manuscript on ATI-1701 efficacy
Premium
The Fly
Appili Therapeutics, colleagues publish manuscript on ATI-1701 efficacy
8M ago
Appili Therapeutics Demonstrates Efficacy of Tularemia Vaccine Candidate
PremiumCompany Announcements
Appili Therapeutics Demonstrates Efficacy of Tularemia Vaccine Candidate
8M ago
Appili Therapeutics Advances Infectious Disease Solutions with LIKMEZ Re-launch and Vaccine Developments
PremiumCompany Announcements
Appili Therapeutics Advances Infectious Disease Solutions with LIKMEZ Re-launch and Vaccine Developments
9M ago
Appili Therapeutics Ends Agreement with Aditxt, Secures Loan Extensions
PremiumCompany Announcements
Appili Therapeutics Ends Agreement with Aditxt, Secures Loan Extensions
10M ago
Appili Therapeutics Faces Termination of Agreement with Aditxt
PremiumCompany Announcements
Appili Therapeutics Faces Termination of Agreement with Aditxt
11M ago
Aditxt announces termination of arrangement agreement with Appili Therapeutics
PremiumThe FlyAditxt announces termination of arrangement agreement with Appili Therapeutics
11M ago
ADTX
Appili Therapeutics Advances Tularemia Vaccine Research
Premium
Company Announcements
Appili Therapeutics Advances Tularemia Vaccine Research
11M ago
Appili Therapeutics publishes manuscript on emergency response to tularemia
Premium
The Fly
Appili Therapeutics publishes manuscript on emergency response to tularemia
11M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >